SynGenSys

SynGenSys is a synthetic biology company specializing in the design of high-performance synthetic promoters and gene circuits for the life sciences industry. Spun out from the University of Sheffield, the company utilizes its proprietary platform to engineer DNA sequences that provide precise control over gene expression in various cell types and tissues. Their technology is applied across gene therapy, cell therapy, and biomanufacturing to improve the safety, efficacy, and yield of advanced therapeutics. SynGenSys partners with pharmaceutical and biotech companies to optimize viral vectors and cell lines through custom-designed regulatory elements. By focusing on the non-coding dark matter of the genome, the company enables more predictable and potent biological products.